Suven Life Sciences Ltd, an Indian CRAMS player,  has been granted  three new patents by the European Patent Office for its research relating to neurodegenerative diseases.

Growing at compounded annual growth rate of nearly 14% in the next few years, the Indian pharmaceutical market is expected to touch USD 40 billion by 2015, predicts  the global management consulting major  Mckinsey and Company.

PV-10, an experimaental drug by Provectus Pharmaceuticals, to treat metastatic melanoma, has shown to be increasing the overall survival rate in patients.

Serum Institute, Panacea Biotech and Bharat Biotech are expected to launch human studies of their H1N1 swine flu vaccine candidates in India by early next year.

Generic drug market in Central and Eastern Europe jumped to €17.2bn in 2008, accounting for around 58% of the pharmaceutical market in the region in terms of value.

Sildenafil, the active drug in the commonly used erectile dysfunction drug Viagra, has been approved to treat pulmonary hypertension in US.

3167 children will participate in a phase 3 trial to be conducted in South Africa to test a vaccine against rotavirus.

Lu AE58054, an add on therapy to improve cognition in Alzheimer's patients is currently in human studies.

Generics leader Teva has filed a lawsuit, besides a Citizen's Petition, against Natco's glatiramer generic

Lysteda supports a natural mechanisms which stops menstrual blood flow each month